---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-044220"
form_type: "8-K"
ticker: "OGEN"
cik: "0001174940"
company_name: "ORAGENICS INC"
filed_at: "2023-12-08T23:59:59+00:00"
generated_at: "2026-06-07T15:26:37.069188+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Oragenics designates 8M Series F Convertible Preferred Stock for Odyssey asset purchase

## Summary
- Filed Certificate of Designation for 8,000,000 shares of Series F Convertible Preferred Stock for the Odyssey Health asset purchase.
- Series F is economically equivalent to common stock; liquidation junior to Class A, B, and Series E Preferred; no dividends, no voting rights.
- Converts 1:1 into common stock upon close of Odyssey purchase, subject to shareholder approval for issuance and 350M authorized share increase.
- Conversion capped at 19.9% of outstanding common stock until NYSE American listing or delisting and change-of-control approval if needed.
- Redemption not permitted; no trading market expected; preemptive rights not provided.

## SEC filing metadata
- accession: 0001493152-23-044220
- form_type: 8-K
- ticker: OGEN
- cik: 0001174940
- company_name: ORAGENICS INC
- filed_at: 2023-12-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1174940/000149315223044220/0001493152-23-044220-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1174940/000149315223044220/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-044220
- JSON: https://secwatch.observer/filing/0001493152-23-044220.json
- Plain text: https://secwatch.observer/filing/0001493152-23-044220.txt

## Key facts
- Governance Changes
  ORAGENICS INC: Filed Certificate of Designation establishing Series F Convertible Preferred Stock (effective 2023-12-04).
  - Change: charter amendment
  - Effective: 2023-12-04
  source text: On December 4, 2023, in anticipation of the the Odyssey Asset Purchase, the Company filed a Certificate of Designation with the Secretary of State for the State of Florida (the “ Certificate of Designation ”) designating 8,000,000 shares out of the authorized but unissued shares of its preferred stock as Series F Convertible Preferred Stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1174940/000149315223044220/0001493152-23-044220-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.